TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs62341639
log Bayes Factor = 0.0198599
Chromosome 4   position 185,159,434  (GRCh37) Explore rs62341639 on Ensembl!
Variant rs62341639 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
H91.9 Hearing loss, unspecified
0.159 0.841 0.000
H91 Other hearing loss
0.116 0.884 0.000
H91.2 Sudden idiopathic hearing loss
0.099 0.901 0.000
H91.1 Presbycusis
0.089 0.911 0.000
H91.8 Other specified hearing loss
0.084 0.916 0.000
H91.0 Ototoxic hearing loss
0.084 0.916 0.000
H91.3 Deaf mutism, not elsewhere classified
0.079 0.921 0.000
H90-H95 Other disorders of ear
0.057 0.943 0.000
H90 Conductive and sensorineural hearing loss
0.049 0.951 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.048 0.952 0.000
H74 Other disorders of middle ear and mastoid
0.045 0.955 0.000
H90.2 Conductive hearing loss, unspecified
0.044 0.956 0.000
H65-H75 Diseases of middle ear and mastoid
0.043 0.957 0.000
Chapter VIII Diseases of the ear and mastoid process
0.042 0.958 0.000
H94 Other disorders of ear in diseases classified elsewhere
0.041 0.959 0.000
H73 Other disorders of tympanic membrane
0.041 0.959 0.000
H73.8 Other specified disorders of tympanic membrane
0.040 0.960 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.038 0.961 0.000
H90.0 Conductive hearing loss, bilateral
0.038 0.962 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.038 0.962 0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.038 0.962 0.000
H90.5 Sensorineural hearing loss, unspecified
0.036 0.963 0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.035 0.965 0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified
0.034 0.966 0.000
H68 Eustachian salpingitis and obstruction
0.033 0.967 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.032 0.968 0.000
H72 Perforation of tympanic membrane
0.032 0.968 0.000
H74.1 Adhesive middle ear disease
0.032 0.968 0.000
H73.1 Chronic myringitis
0.032 0.968 0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.032 0.968 0.000
H74.0 Tympanosclerosis
0.032 0.968 0.000
H74.9 Disorder of middle ear and mastoid, unspecified
0.031 0.968 0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.031 0.969 0.000
H67 Otitis media in diseases classified elsewhere
0.031 0.969 0.000
H90.3 Sensorineural hearing loss, bilateral
0.030 0.970 0.000
H69 Other disorders of Eustachian tube
0.030 0.970 0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere
0.029 0.970 0.000
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere
0.029 0.970 0.000
H73.0 Acute myringitis
0.029 0.970 0.000
H60-H62 Diseases of external ear
0.029 0.971 0.000
H74.2 Discontinuity and dislocation of ear ossicles
0.028 0.971 0.000
H74.4 Polyp of middle ear
0.028 0.972 0.000
H71 Cholesteatoma of middle ear
0.027 0.973 0.000
H70 Mastoiditis and related conditions
0.027 0.973 0.000
H68.1 Obstruction of Eustachian tube
0.026 0.974 0.000
H66 Suppurative and unspecified otitis media
0.026 0.974 0.000
H93 Other disorders of ear, not elsewhere classified
0.026 0.974 0.000
H72.8 Other perforations of tympanic membrane
0.025 0.975 0.000
H72.9 Perforation of tympanic membrane, unspecified
0.025 0.975 0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified
0.025 0.975 0.000
H95.8 Other postprocedural disorders of ear and mastoid process
0.025 0.975 0.000
H73.9 Disorder of tympanic membrane, unspecified
0.024 0.976 0.000
H69.8 Other specified disorders of Eustachian tube
0.024 0.976 0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity
0.024 0.976 0.000
H68.0 Eustachian salpingitis
0.024 0.976 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.024 0.976 0.000
H60 Otitis externa
0.023 0.977 0.000
H72.1 Attic perforation of tympanic membrane
0.023 0.977 0.000
H72.2 Other marginal perforations of tympanic membrane
0.022 0.977 0.000
H67.8 Otitis media in other diseases classified elsewhere
0.022 0.978 0.000
H67.1 Otitis media in viral diseases classified elsewhere
0.022 0.978 0.000
H67.0 Otitis media in bacterial diseases classified elsewhere
0.022 0.978 0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.022 0.978 0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.022 0.978 0.000
H92 Otalgia and effusion of ear
0.022 0.978 0.000
H69.0 Patulous Eustachian tube
0.022 0.978 0.000
H72.0 Central perforation of tympanic membrane
0.022 0.978 0.000
H62 Disorders of external ear in diseases classified elsewhere
0.021 0.979 0.000
H60.9 Otitis externa, unspecified
0.021 0.979 0.000
Z93.2 Ileostomy status
0.020 0.980 0.000
H60.5 Acute otitis externa, non-infective
0.020 0.980 0.000
H66.4 Suppurative otitis media, unspecified
0.020 0.980 0.000
H66.3 Other chronic suppurative otitis media
0.020 0.980 0.000
H95.1 Other disorders following mastoidectomy
0.019 0.980 0.000
H70.8 Other mastoiditis and related conditions
0.019 0.980 0.000
H70.2 Petrositis
0.019 0.980 0.000
H70.1 Chronic mastoiditis
0.019 0.980 0.000
H70.0 Acute mastoiditis
0.019 0.980 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.019 0.981 0.000
H93.3 Disorders of acoustic nerve
0.019 0.981 0.000
H93.2 Other abnormal auditory perceptions
0.019 0.981 0.000
H93.0 Degenerative and vascular disorders of ear
0.019 0.981 0.000
H93.8 Other specified disorders of ear
0.018 0.981 0.000
H66.0 Acute suppurative otitis media
0.018 0.981 0.000
N03.9 Unspecified
0.018 0.982 0.000
H66.2 Chronic atticoantral suppurative otitis media
0.018 0.982 0.000
H69.9 Eustachian tube disorder, unspecified
0.017 0.983 0.000
H60.2 Malignant otitis externa
0.017 0.983 0.000
H60.0 Abscess of external ear
0.017 0.983 0.000
H60.1 Cellulitis of external ear
0.017 0.983 0.000
H61 Other disorders of external ear
0.016 0.984 0.000
H92.2 Otorrhagia
0.016 0.984 0.000
H62.8 Other disorders of external ear in diseases classified elsewhere
0.015 0.985 0.000
H62.4 Otitis externa in other diseases classified elsewhere
0.015 0.985 0.000
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere
0.015 0.985 0.000
H62.2 Otitis externa in mycoses
0.015 0.985 0.000
H62.1 Otitis externa in viral diseases classified elsewhere
0.015 0.985 0.000
H62.0 Otitis externa in bacterial diseases classified elsewhere
0.015 0.985 0.000
H60.8 Other otitis externa
0.015 0.985 0.000
H70.9 Mastoiditis, unspecified
0.015 0.985 0.000
H60.4 Cholesteatoma of external ear
0.014 0.985 0.000
H93.9 Disorder of ear, unspecified
0.014 0.986 0.000
H60.3 Other infective otitis externa
0.014 0.986 0.000
N03 Chronic nephritic syndrome
0.014 0.986 0.000
H61.8 Other specified disorders of external ear
0.013 0.986 0.000
H61.3 Acquired stenosis of external ear canal
0.013 0.987 0.000
R21 Rash and other nonspecific skin eruption
0.013 0.987 0.000
H92.0 Otalgia
0.013 0.987 0.000
H65 Nonsuppurative otitis media
0.013 0.987 0.000
H93.1 Tinnitus
0.013 0.987 0.000
H80-H83 Diseases of inner ear
0.013 0.987 0.000
H66.9 Otitis media, unspecified
0.012 0.987 0.000
Y52 Agents primarily affecting the cardiovascular system
0.012 0.988 0.000
D24 Benign neoplasm of breast
0.000 0.989 0.011
H61.1 Non-infective disorders of pinna
0.011 0.989 0.000
N00-N08 Glomerular diseases
0.010 0.989 0.000
N05 Unspecified nephritic syndrome
0.010 0.990 0.000
N05.8 Other
0.010 0.990 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.010 0.990 0.000
N03.8 Other
0.010 0.990 0.000
N03.7 Diffuse crescentic glomerulonephritis
0.010 0.990 0.000
N03.6 Dense deposit disease
0.010 0.990 0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.010 0.990 0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.010 0.990 0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.010 0.990 0.000
N03.2 Diffuse membranous glomerulonephritis
0.010 0.990 0.000
N03.1 Focal and segmental glomerular lesions
0.010 0.990 0.000
N03.0 Minor glomerular abnormality
0.010 0.990 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.010 0.990 0.000
H61.9 Disorder of external ear, unspecified
0.010 0.990 0.000
H65.1 Other acute nonsuppurative otitis media
0.009 0.990 0.000
H82 Vertiginous syndromes in diseases classified elsewhere
0.009 0.991 0.000
H61.0 Perichondritis of external ear
0.009 0.991 0.000
H65.2 Chronic serous otitis media
0.009 0.991 0.000
N04 Nephrotic syndrome
0.009 0.991 0.000
H65.0 Acute serous otitis media
0.009 0.991 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.009 0.991 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.009 0.991 0.000
Y52.7 Peripheral vasodilators
0.009 0.991 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.009 0.991 0.000
N05.2 Diffuse membranous glomerulonephritis
0.008 0.991 0.000
H61.2 Impacted cerumen
0.008 0.992 0.000
H65.4 Other chronic nonsuppurative otitis media
0.008 0.992 0.000
N05.9 Unspecified
0.008 0.992 0.000
N04.9 Unspecified
0.008 0.992 0.000
H83 Other diseases of inner ear
0.008 0.992 0.000
N02 Recurrent and persistent haematuria
0.008 0.992 0.000
H80 Otosclerosis
0.008 0.992 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.008 0.992 0.000
N06 Isolated proteinuria with specified morphological lesion
0.008 0.992 0.000
N01 Rapidly progressive nephritic syndrome
0.008 0.992 0.000
N00 Acute nephritic syndrome
0.008 0.992 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.008 0.992 0.000
N05.6 Dense deposit disease
0.008 0.992 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.008 0.992 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.008 0.992 0.000
N05.0 Minor glomerular abnormality
0.008 0.992 0.000
Y52.1 Calcium-channel blockers
0.008 0.992 0.000
N05.7 Diffuse crescentic glomerulonephritis
0.008 0.992 0.000
K51.2 Ulcerative (chronic) proctitis
0.008 0.992 0.000
N02.8 Other
0.007 0.993 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.007 0.993 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.007 0.993 0.000
N05.1 Focal and segmental glomerular lesions
0.007 0.993 0.000
H65.3 Chronic mucoid otitis media
0.007 0.993 0.000
G31.9 Degenerative disease of nervous system, unspecified
0.000 0.993 0.007
N04.8 Other
0.007 0.993 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.007 0.993 0.000
N04.6 Dense deposit disease
0.007 0.993 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.007 0.993 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.007 0.993 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.007 0.993 0.000
N04.2 Diffuse membranous glomerulonephritis
0.007 0.993 0.000
N04.1 Focal and segmental glomerular lesions
0.007 0.993 0.000
N04.0 Minor glomerular abnormality
0.007 0.993 0.000
H80.0 Otosclerosis involving oval window, nonobliterative
0.006 0.993 0.000
N02.2 Diffuse membranous glomerulonephritis
0.006 0.994 0.000
H83.3 Noise effects on inner ear
0.006 0.994 0.000
H83.2 Labyrinthine dysfunction
0.006 0.994 0.000
H83.1 Labyrinthine fistula
0.006 0.994 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.006 0.994 0.000
H83.9 Disease of inner ear, unspecified
0.006 0.994 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.006 0.994 0.000
N02.6 Dense deposit disease
0.006 0.994 0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.994 0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.994 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.994 0.000
N02.1 Focal and segmental glomerular lesions
0.006 0.994 0.000
N02.0 Minor glomerular abnormality
0.006 0.994 0.000
H80.8 Other otosclerosis
0.006 0.994 0.000
H80.2 Cochlear otosclerosis
0.006 0.994 0.000
H80.1 Otosclerosis involving oval window, obliterative
0.006 0.994 0.000
N00.9 Unspecified
0.006 0.994 0.000
N00.8 Other
0.006 0.994 0.000
N00.7 Diffuse crescentic glomerulonephritis
0.006 0.994 0.000
N00.6 Dense deposit disease
0.006 0.994 0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.994 0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.994 0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.994 0.000
N00.2 Diffuse membranous glomerulonephritis
0.006 0.994 0.000
N00.1 Focal and segmental glomerular lesions
0.006 0.994 0.000
N00.0 Minor glomerular abnormality
0.006 0.994 0.000
N01.9 Unspecified
0.006 0.994 0.000
N01.8 Other
0.006 0.994 0.000
N01.7 Diffuse crescentic glomerulonephritis
0.006 0.994 0.000
N01.6 Dense deposit disease
0.006 0.994 0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.994 0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.994 0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.994 0.000
N01.2 Diffuse membranous glomerulonephritis
0.006 0.994 0.000
N01.1 Focal and segmental glomerular lesions
0.006 0.994 0.000
N01.0 Minor glomerular abnormality
0.006 0.994 0.000
N06.9 Unspecified
0.006 0.994 0.000
N06.8 Other
0.006 0.994 0.000
N06.7 Diffuse crescentic glomerulonephritis
0.006 0.994 0.000
N06.6 Dense deposit disease
0.006 0.994 0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.994 0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.994 0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.994 0.000
N06.2 Diffuse membranous glomerulonephritis
0.006 0.994 0.000
N06.1 Focal and segmental glomerular lesions
0.006 0.994 0.000
N06.0 Minor glomerular abnormality
0.006 0.994 0.000
N07.9 Unspecified
0.006 0.994 0.000
N07.8 Other
0.006 0.994 0.000
N07.7 Diffuse crescentic glomerulonephritis
0.006 0.994 0.000
N07.6 Dense deposit disease
0.006 0.994 0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.994 0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.994 0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.994 0.000
N07.2 Diffuse membranous glomerulonephritis
0.006 0.994 0.000
N07.1 Focal and segmental glomerular lesions
0.006 0.994 0.000
N07.0 Minor glomerular abnormality
0.006 0.994 0.000
H92.1 Otorrhoea
0.005 0.994 0.001
H83.8 Other specified diseases of inner ear
0.005 0.994 0.000
C50.4 Upper-outer quadrant of breast
0.000 0.995 0.005
H83.0 Labyrinthitis
0.005 0.995 0.000
M19.97 Arthrosis, unspecified (Ankle and foot)
0.000 0.995 0.005
H65.9 Nonsuppurative otitis media, unspecified
0.005 0.995 0.000
Z50.0 Cardiac rehabilitation
0.000 0.995 0.005
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.005 0.995 0.000
N08.8 Glomerular disorders in other diseases classified elsewhere
0.004 0.995 0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.004 0.995 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.004 0.995 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.004 0.995 0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.004 0.995 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.004 0.996 0.000
C92.0 Acute myeloid leukaemia
0.004 0.996 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.004 0.996 0.000
K75.9 Inflammatory liver disease, unspecified
0.004 0.996 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.004 0.996 0.000
Y54.3 Benzothiadiazine derivatives
0.004 0.996 0.000
R40.0 Somnolence
0.000 0.996 0.004
G31 Other degenerative diseases of nervous system, not elsewhere classified
0.000 0.996 0.004
G31.0 Circumscribed brain atrophy
0.000 0.996 0.004
N18.5 Chronic kidney disease, stage 5
0.004 0.996 0.000
T82.1 Mechanical complication of cardiac electronic device
0.003 0.997 0.000
Y40 Systemic antibiotics
0.003 0.997 0.000
K62.4 Stenosis of anus and rectum
0.003 0.997 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
Y56.9 Topical agent, unspecified
0.003 0.997 0.000
Y56.8 Other topical agents
0.003 0.997 0.000
Y56.7 Dental drugs, topically applied
0.003 0.997 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.003 0.997 0.000
Y56.5 Ophthalmological drugs and preparations
0.003 0.997 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.003 0.997 0.000
Y56.3 Emollients, demulcents and protectants
0.003 0.997 0.000
Y56.2 Local astringents and local detergents
0.003 0.997 0.000
Y56.1 Antipruritics
0.003 0.997 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.003 0.997 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
B18.2 Chronic viral hepatitis C
0.003 0.997 0.000
Z99.2 Dependence on renal dialysis
0.003 0.997 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.003 0.997 0.000
Y59 Other and unspecified vaccines and biological substances
0.003 0.997 0.000
Y40.7 Antifungal antibiotics, systemically used
0.003 0.997 0.000
Z93 Artificial opening status
0.003 0.997 0.000
Y40.6 Rifamycins
0.003 0.997 0.000
Y40.4 Tetracyclines
0.003 0.997 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.003 0.997 0.000
Y40.5 Aminoglycosides
0.003 0.997 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.003 0.997 0.000
Y58 Bacterial vaccines
0.003 0.997 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.003 0.997 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.003 0.997 0.000
Y49.5 Other antipsychotics and neuroleptics
0.003 0.997 0.000
O36.5 Maternal care for poor foetal growth
0.003 0.997 0.000
Z93.4 Other artificial openings of gastro-intestinal tract status
0.003 0.997 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
C92.4 Acute promyelocytic leukaemia
0.003 0.997 0.000
G31.1 Senile degeneration of brain, not elsewhere classified
0.000 0.997 0.003
Z47.8 Other specified orthopaedic follow-up care
0.000 0.997 0.003
C92 Myeloid leukaemia
0.003 0.997 0.000
D04.7 Skin of lower limb, including hip
0.003 0.997 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.003 0.997 0.000
Z93.8 Other artificial opening status
0.003 0.997 0.000
Q61.3 Polycystic kidney, unspecified
0.003 0.997 0.000
Y40.9 Systemic antibiotic, unspecified
0.003 0.997 0.000
Y40.2 Chloramphenicol group
0.003 0.997 0.000
Y40.0 Penicillins
0.003 0.997 0.000
Y59.3 Immunoglobulin
0.003 0.997 0.000
Y48 Anaesthetics and therapeutic gases
0.003 0.997 0.000
H80.9 Otosclerosis, unspecified
0.002 0.997 0.000
Z93.9 Artificial opening status, unspecified
0.003 0.997 0.000
C50.8 Overlapping lesion of breast
0.000 0.997 0.003
Y49.9 Psychotropic drug, unspecified
0.002 0.997 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.997 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.997 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.997 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.997 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.997 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.997 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.002 0.997 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.003 0.997 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.002 0.997 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.002 0.997 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.002 0.997 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.002 0.997 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.002 0.997 0.000
Y51.0 Anticholinesterase agents
0.002 0.997 0.000
C92.7 Other myeloid leukaemia
0.002 0.997 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.002 0.997 0.000
Y46.6 Other and unspecified antiepileptics
0.002 0.997 0.000
Y54.9 Mineral salts, not elsewhere classified
0.002 0.997 0.000
Y54.7 Agents affecting calcification
0.002 0.997 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.002 0.997 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.002 0.997 0.000
Y54.0 Mineralocorticoids
0.002 0.997 0.000
Y59.9 Vaccine or biological substance, unspecified
0.002 0.997 0.000
Y59.8 Other specified vaccines and biological substances
0.002 0.997 0.000
Y59.2 Protozoal vaccines
0.002 0.997 0.000
Y59.1 Rickettsial vaccines
0.002 0.997 0.000
Y59.0 Viral vaccines
0.002 0.997 0.000
Y40.8 Other systemic antibiotics
0.002 0.997 0.000
I86.1 Scrotal varices
0.000 0.997 0.003
Y46.2 Hydantoin derivatives
0.002 0.997 0.000
Y44 Agents primarily affecting blood constituents
0.002 0.997 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.000 0.997 0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.002 0.997 0.000
B18 Chronic viral hepatitis
0.002 0.997 0.000
G31.2 Degeneration of nervous system due to alcohol
0.000 0.998 0.002
Y54.8 Agents affecting uric acid metabolism
0.002 0.998 0.000
C92.9 Myeloid leukaemia, unspecified
0.002 0.998 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.002 0.998 0.000
Y95 Nosocomial condition
0.000 0.998 0.002
Y46.8 Antispasticity drugs
0.002 0.998 0.000
Y46.7 Anti-Parkinsonism drugs
0.002 0.998 0.000
Y46.5 Valproic acid
0.002 0.998 0.000
Y46.3 Deoxybarbiturates
0.002 0.998 0.000
Y46.1 Oxazolidinediones
0.002 0.998 0.000
Y46.0 Succinimides
0.002 0.998 0.000
Y45.5 4-Aminophenol derivatives
0.002 0.998 0.000
Y50.9 Central nervous system stimulant, unspecified
0.002 0.998 0.000
Y50.8 Other central nervous system stimulants
0.002 0.998 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.002 0.998 0.000
Y50.1 Opioid receptor antagonists
0.002 0.998 0.000
Y50.0 Analeptics
0.002 0.998 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.998 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.002 0.998 0.000
Y55.5 Anticommon cold drugs
0.002 0.998 0.000
Y55.4 Expectorants
0.002 0.998 0.000
Y55.3 Antitussives
0.002 0.998 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.002 0.998 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.002 0.998 0.000
Y55.0 Oxytocic drugs
0.002 0.998 0.000
Y58.9 Other and unspecified bacterial vaccines
0.002 0.998 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.002 0.998 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.002 0.998 0.000
Y58.5 Diphtheria vaccine
0.002 0.998 0.000
Y58.4 Tetanus vaccine
0.002 0.998 0.000
Y58.3 Plague vaccine
0.002 0.998 0.000
Y58.2 Cholera vaccine
0.002 0.998 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.002 0.998 0.000
Y58.0 BCG vaccine
0.002 0.998 0.000
Y49.2 Other and unspecified antidepressants
0.002 0.998 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.002 0.998 0.000
B18.1 Chronic viral hepatitis B without delta-agent
0.002 0.998 0.000
V17.0 Driver injured in nontraffic accident
0.002 0.998 0.000
S22.20 Fracture of sternum (closed)
0.002 0.998 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.002 0.998 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.002 0.998 0.000
C92.5 Acute myelomonocytic leukaemia
0.002 0.998 0.000
C92.3 Myeloid sarcoma
0.002 0.998 0.000
C92.2 Subacute myeloid leukaemia
0.002 0.998 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
G31.8 Other specified degenerative diseases of nervous system
0.000 0.998 0.002
T82.4 Mechanical complication of vascular dialysis catheter
0.002 0.998 0.000
V17.4 Driver injured in traffic accident
0.002 0.998 0.000
Z93.3 Colostomy status
0.002 0.998 0.000
Y45.1 Salicylates
0.002 0.998 0.000
Y40.3 Macrolides
0.002 0.998 0.000
Y41.5 Antiviral drugs
0.002 0.998 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.002 0.998 0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.002 0.998 0.000
N84.2 Polyp of vagina
0.002 0.998 0.000
Y48.2 Other and unspecified general anaesthetics
0.002 0.998 0.000
Z93.5 Cystostomy status
0.002 0.998 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.000 0.998 0.002
N18.0 End-stage renal disease
0.002 0.998 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.002 0.998 0.000
Y48.5 Therapeutic gases
0.002 0.998 0.000
Y48.1 Parenteral anaesthetics
0.002 0.998 0.000
Y48.0 Inhaled anaesthetics
0.002 0.998 0.000
M77.97 Enthesopathy, unspecified (Ankle and foot)
0.002 0.998 0.000
Y46.4 Iminostilbenes
0.002 0.998 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.002 0.998 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.002 0.998 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.002 0.998 0.000
Y47.4 Bromine compounds
0.002 0.998 0.000
Y47.3 Paraldehyde
0.002 0.998 0.000
Y47.2 Chloral derivatives
0.002 0.998 0.000
Y47.0 Barbiturates, not elsewhere classified
0.002 0.998 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.002 0.998 0.000
Y41.4 Anthelminthics
0.002 0.998 0.000
Y41.3 Other antiprotozoal drugs
0.002 0.998 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.002 0.998 0.000
Y41.1 Antimycobacterial drugs
0.002 0.998 0.000
Y54.4 Loop [high-ceiling] diuretics
0.002 0.998 0.000
C62.9 Testis, unspecified
0.000 0.998 0.002
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.998 0.002
Y41.0 Sulphonamides
0.002 0.998 0.000
M25.74 Osteophyte (Hand)
0.000 0.998 0.002
G44.2 Tension-type headache
0.002 0.998 0.000
Y54.5 Other diuretics
0.002 0.998 0.000
C92.1 Chronic myeloid leukaemia
0.002 0.998 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.002 0.998 0.000
Y44.7 Plasma substitutes
0.002 0.998 0.000
Y44.6 Natural blood and blood products
0.002 0.998 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.002 0.998 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.998 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.002 0.998 0.000
B18.9 Chronic viral hepatitis, unspecified
0.002 0.998 0.000
B18.8 Other chronic viral hepatitis
0.002 0.998 0.000
B18.0 Chronic viral hepatitis B with delta-agent
0.002 0.998 0.000
Y48.3 Local anaesthetics
0.002 0.998 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.002 0.998 0.000
Z73.3 Stress, not elsewhere classified
0.002 0.998 0.000
J33.9 Nasal polyp, unspecified
0.002 0.998 0.000
X59.2 School, other institution and public administrative area
0.002 0.998 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.002 0.998 0.000
Y44.5 Thrombolytic drugs
0.002 0.998 0.000
Y45.4 Antirheumatics
0.002 0.998 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.002 0.998 0.000
Y57 Other and unspecified drugs and medicaments
0.002 0.998 0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.998 0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.998 0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)
0.002 0.998 0.000
M00.94 Pyogenic arthritis, unspecified (Hand)
0.002 0.998 0.000
W84.2 School, other institution and public administrative area
0.002 0.998 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.998 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.002 0.998 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
Y53.7 Emetics
0.002 0.998 0.000
Y53.6 Antidiarrhoeal drugs
0.002 0.998 0.000
Y53.5 Digestants
0.002 0.998 0.000
Y53.3 Saline and osmotic laxatives
0.002 0.998 0.000
Y53.2 Stimulant laxatives
0.002 0.998 0.000
Y53.0 Histamine H2-receptor antagonists
0.002 0.998 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.002 0.998 0.000
J32.2 Chronic ethmoidal sinusitis
0.002 0.998 0.000
C50 Malignant neoplasm of breast
0.000 0.998 0.002
J46 Status asthmaticus
0.002 0.998 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.000 0.998 0.002
M00.9 Pyogenic arthritis, unspecified
0.002 0.998 0.000
S50.9 Superficial injury of forearm, unspecified
0.002 0.998 0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts
0.002 0.998 0.000
M00.91 Pyogenic arthritis, unspecified (Shoulder region)
0.002 0.998 0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts
0.002 0.998 0.000
V17.9 Unspecified pedal cyclist injured in traffic accident
0.002 0.998 0.000
V17.5 Passenger injured in traffic accident
0.002 0.998 0.000
V17.3 Person injured while boarding or alighting
0.002 0.998 0.000
V17.2 Unspecified pedal cyclist injured in nontraffic accident
0.002 0.998 0.000
V17.1 Passenger injured in nontraffic accident
0.002 0.998 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.002 0.998 0.000
Y48.4 Anaesthetic, unspecified
0.002 0.998 0.000
Y57.6 Other diagnostic agents
0.002 0.998 0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)
0.000 0.998 0.002
R57.2 Septic shock
0.002 0.998 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.000 0.998 0.002
W84 Unspecified threat to breathing
0.002 0.998 0.000
V40-V49 Car occupant injured in transport accident
0.002 0.998 0.000
R45.8 Other symptoms and signs involving emotional state
0.002 0.998 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.002 0.998 0.000
X59 Exposure to unspecified factor
0.002 0.998 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.001 0.998 0.001
W75-W84 Other accidental threats to breathing
0.002 0.998 0.000
V11.4 Driver injured in traffic accident
0.002 0.998 0.000
Q61 Cystic kidney disease
0.002 0.998 0.000
C50.6 Axillary tail of breast
0.000 0.998 0.002
Y47.1 Benzodiazepines
0.001 0.998 0.000
V10-V19 Pedal cyclist injured in transport accident
0.002 0.998 0.000
M19.27 Other secondary arthrosis (Ankle and foot)
0.002 0.998 0.000
C50.5 Lower-outer quadrant of breast
0.000 0.998 0.002
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.998 0.002
V11 Pedal cyclist injured in collision with other pedal cycle
0.002 0.998 0.000
G44.0 Cluster headache syndrome
0.002 0.998 0.000
Z93.6 Other artificial openings of urinary tract status
0.002 0.998 0.000
W80 Inhalation and ingestion of other objects causing obstruction of respiratory tract
0.002 0.998 0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)
0.000 0.998 0.002
W18.3 Sports and athletics area
0.002 0.998 0.000
Y53.4 Other laxatives
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.